MEDI-8367

N/A

Report date: 2026/01/03 20:00:09

Base Information

Drug NameMEDI-8367
Drug Alias NameMEDI-8367
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A